tradingkey.logo

Sunshine Biopharma Inc

SBFMW
View Detailed Chart

0.220USD

-0.067-23.53%
Close 05/09, 16:00ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Sunshine Biopharma Inc

0.220

-0.067-23.53%
Intraday
1m
30m
1h
D
W
M
D

Today

-23.53%

5 Days

+6.02%

1 Month

-61.80%

6 Months

+37.59%

Year to Date

+36.73%

1 Year

+56.81%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(1)
Buy(4)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.054
Sell
RSI(14)
38.711
Neutral
STOCH(KDJ)(9,3,3)
8.941
Oversold
ATR(14)
0.105
Low Volatility
CCI(14)
-211.696
Oversold
Williams %R
100.000
Oversold
TRIX(12,20)
-0.574
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
0.167
Buy
MA10
0.202
Buy
MA20
0.266
Sell
MA50
0.239
Sell
MA100
0.218
Buy
MA200
0.164
Buy

News

More news coming soon, stay tuned...

Company

Sunshine Biopharma Inc. is a pharmaceutical company engaged in offering and researching life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has approximately 70 generic prescription drugs on the market in Canada. In addition, the Company is conducting a proprietary drug development program which is comprised of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for the treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The Company operates two wholly owned subsidiaries: Nora Pharma Inc., which has a portfolio of pharmaceutical products consisting of various prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells nonprescription over-the-counter (OTC) products.
Company codeSBFMW
CompanySunshine Biopharma Inc
CEODr. Steve N. Slilaty
Websitehttps://www.sunshinebiopharma.com/